Jul 24, 2020

Moderna loses challenge to Arbutus patent on vaccine technology

Posted by in category: biotech/medical

(Reuters) — Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.

Leave a reply